Konu "Atrial Fibrillation" için Dahili Tıp Bilimleri Bölümü Koleksiyonu listeleme
Toplam kayıt 12, listelenen: 1-12
-
Cardiotrophin-1: A new predictor of atrial fibrillation relapses after successful cardioversion
(Assoc Basic Medical Sci Federation Bosnia & Herzegovina Sarajevo, 2015)We aimed to investigate whether or not cardiotrophin-1 (CT-1) can be used as a predictor of sinus rhythm constancy in patients with atrial fibrillation (AF) converted to sinus rhythm. Thirty two patients with AF (48-78 ... -
Comparison of the Stroke Prevention Strategies in the Aegean Region with the Other Regions of Turkey
(Excerpta Medica Inc-Elsevier Science Inc, 2017)Epidemiological characteristics and treatment modalities of non-valvular atrial fibrillation (NVAF) may differ according to geographical distribution in Turkey. -
Guideline-adherent therapy for stroke prevention in atrial fibrillation in different health care settings: Results from RAMSES study
(Elsevier Science Bv, 2017)Objective: No studies have been conducted in Turkey to compare the quality of stroke prevention therapies provided in different healthcare settings in patients with atrial fibrillation (AF). Therefore, we aimed to evaluate ... -
Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study
(Springer, 2017)The definition of non-valvular atrial fibrillation (NVAF) is controversial. We aimed to assess the impact of valvular heart disease on stroke prevention strategies in NVAF patients. The RAMSES study was a multicenter and ... -
Metoprolol vs ivabradine in patients with mitral stenosis
(Elsevier Ireland Ltd, 2016)[No abstract available] -
Non-vitamin K antagonist oral anticoagulants in valvular atrial fibrillation
(Elsevier Ireland Ltd, 2016)Letter to Editor -
Rationale, design and methodology of the RAMSES Study: ReAl-life Multicenter Survey Evaluating Stroke Prevention Strategies
(Turkish Soc Cardiology, 2016)Objective: Atrial fibrillation is the most common arrhythmia and is associated with a five-fold increased risk of thromboembolic events. Vitamin K antagonists (VKAs) have been the mainstay of oral anticoagulant prophylaxis ... -
ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in non-valvular atrial fibrillation (RAMSES study)
(Turkish Soc Cardiology, 2016)Objective: Data regarding stroke prevention strategies in non-valvular atrial fibrillation (NVAF) are limited to vitamin K antagonists (VKAs). This study aimed to evaluate real-life stroke prevention strategies for NVAF ... -
Real-life use of digoxin in patients with non-valvular atrial fibrillation: data from the RAMSES study
(Wiley, 2016)What is known and objectiveAlthough inappropriate use of digoxin has been described in various populations, a real-world evaluation of patterns of digoxin prescription has not been well studied in patients with atrial ... -
Real-World Clinical Characteristics and Treatment Patterns of Individuals Aged 80 and Older with Nonvalvular Atrial Fibrillation: Results from the ReAl-life Multicenter Survey Evaluating Stroke Study
(Wiley, 2017)ObjectivesTo compare the clinical characteristics of and use of oral anticoagulant (OAC) therapy in individuals aged 80 and older with atrial fibrillation (AF) with those of individuals younger than 80 with AF in clinical ... -
Suboptimal use of non-vitamin K antagonist oral anticoagulants: Results from the RAMSES study
(Lippincott Williams & Wilkins, 2016)This study aimed to investigate the potential misuse of novel oral anticoagulants (NOACs) and the physicians' adherence to current European guideline recommendations in real-world using a large dataset from Real-life ...